You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T3011

Showing 26 - 50 of 203
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HBV, Chronic HBV Infection Trial in Worldwide (TAF, TDF, TAF Placebo)

Active, not recruiting
Has Results
  • HBV
  • Chronic HBV Infection
  • Los Angeles, California
  • +159 more
Mar 17, 2022

Psoriasis Vulgaris Trial in Belgium (Venapuncture, Dried blood spot, Dose reduction)

Terminated
  • Psoriasis Vulgaris
  • Venapuncture
  • +2 more
  • Ghent, East-Flanders, Belgium
  • +6 more
Dec 19, 2022

Cataract Trial in Worldwide (ACRYSOF® IQ Extended Depth of Focus IOL, ACRYSOF® IQ Monofocal IOL, Cataract surgery)

Completed
Has Results
  • Cataract
  • ACRYSOF® IQ Extended Depth of Focus IOL
  • +2 more
  • Sydney, New South Wales, Australia
  • +20 more
Mar 25, 2020

Metastatic Colorectal Cancer Trial in Worldwide (Cetuximab, Panitumumab)

Completed
Has Results
  • Metastatic Colorectal Cancer
  • Stockton, California
  • +151 more
Sep 8, 2022

Endometrial Tumors Trial in Worldwide (Paclitaxel, Sapanisertib, MLN1117)

Completed
Has Results
  • Endometrial Neoplasms
  • Birmingham, Alabama
  • +77 more
Oct 28, 2021

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (QBW251, Placebo, COPD maintenance background therapy)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Andalusia, Alabama
  • +147 more
Jul 27, 2022

Opioid Free Anaesthesia in Oncologic Gynaecological Surgery: Is

Completed
  • Cervix Cancer
  • +3 more
  • Madrid, Spain
    Julia Albano Polo
Jul 4, 2022

Type 1 Diabetes Trial in Worldwide (Teplizumab, Placebo)

Completed
  • Type 1 Diabetes Mellitus
  • Birmingham, Alabama
  • +114 more
Feb 4, 2022

Malnutrition, Manihot Species Poisoning Trial in Kinshasa (Wetting method (WTM), Mediational Intervention for Sensitizing

Completed
  • Malnutrition
  • Manihot Species Poisoning
  • Wetting method (WTM)
  • Mediational Intervention for Sensitizing Caregivers (MISC)
  • Kinshasa, Congo, The Democratic Republic of the
    Institute National of Research National (INRB)
Dec 8, 2022

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (Danirixin, Danirixin matching , Standard of care)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Birmingham, Alabama
  • +63 more
Oct 6, 2020

Idiopathic Pulmonary Fibrosis Trial in Worldwide (BMS-986278, BMS-986278 Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Birmingham, Alabama
  • +442 more
Aug 15, 2023

Tumors, Cancer, Caregiver Trial in Philadelphia

Recruiting
  • Neoplasms
  • +2 more
    • Philadelphia, Pennsylvania
      Cancer Support Community Research & Training Institute
    Jan 30, 2022

    Hepatocellular Carcinoma Trial in Changsha (HIPEC+tislelizumab + targeted therapy)

    Active, not recruiting
    • Hepatocellular Carcinoma
    • HIPEC+tislelizumab + targeted therapy
    • Changsha, Hunan, China
      Hunan Provincial People's Hospital(The First Affiliated Hospital
    Sep 19, 2022

    Crohn Disease Trial in Worldwide (Etrolizumab)

    Active, not recruiting
    • Crohn Disease
    • Arcadia, California
    • +291 more
    Nov 11, 2022

    Comparative Metabolomics in Diabetes Patients From Sri Lanka and

    Terminated
    • Diabetes Mellitus, Type 2
    • Clinical examination
    • +2 more
    • Bern, Switzerland
      University Hospital Inselspital, Berne
    Mar 14, 2023

    Color Blindness, Color Vision Defects, Color Blindness, Green Trial in San Antonio (Experimental Group 1: Color Correcting

    Recruiting
    • Color Blindness
    • +3 more
    • Experimental Group 1: Color Correcting Lenses
    • +4 more
    • San Antonio, Texas
      University of the Incarnate Word Rosenberg School of Optometry
    Jul 28, 2022

    Childhood Cranial and Craniospinal Tumors Survivors

    Completed
    • Tumors of the Central Nervous System
    • Childhood Cancer Survivors
    • 12-lead ECG, hormone and lipid blood tests, echocardiography (Echo-CG), cardiopulmonary exercise testing (CPET) and pulse wave analysis
    • Moscow, Russian Federation
      I.M. Sechenov First Moscow State Medical University (Sechenov Un
    Dec 6, 2022

    Ulcerative Colitis Trial in Worldwide (Adalimumab, Adalimumab Placebo, Etrolizumab)

    Completed
    Has Results
    • Ulcerative Colitis
    • Orlando, Florida
    • +89 more
    Jul 21, 2021

    Systemic Lupus Erythematosus (SLE) Trial in Worldwide (BIIB059, BIIB059-matching )

    Recruiting
    • Systemic Lupus Erythematosus (SLE)
    • Mesa, Arizona
    • +280 more
    Jul 20, 2022

    Ulcerative Colitis Trial in Worldwide (Etrolizumab)

    Active, not recruiting
    • Ulcerative Colitis
    • Birmingham, Alabama
    • +413 more
    Dec 21, 2022

    Acute Myeloid Leukemia (AML), Cancer Trial in Worldwide (Venetoclax, Azacitidine, Best Supportive Care (BSC))

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Cancer
    • Scottsdale, Arizona
    • +169 more
    Aug 23, 2022

    Melanoma Trial in Worldwide (Pembrolizumab, Vibostolimab, V937)

    Recruiting
    • Melanoma
    • Pembrolizumab
    • +5 more
    • Los Angeles, California
    • +28 more
    Jan 25, 2023

    Sleep Trial in Lubbock (Sleep duration)

    Completed
    Has Results
    • Sleep
    • Sleep duration
    • Lubbock, Texas
      Texas Tech University
    Jan 11, 2023

    Ulcerative Colitis Trial in Worldwide (Etrozulimab, Placebo)

    Completed
    Has Results
    • Ulcerative Colitis
    • Birmingham, Alabama
    • +183 more
    Jul 22, 2021

    Wet Macular Degeneration Trial in Worldwide (Faricimab, Aflibercept, Sham Procedure)

    Completed
    Has Results
    • Wet Macular Degeneration
    • Mesa, Arizona
    • +159 more
    Apr 6, 2022